According to Merck's latest financial reports the company's total debt is $30.69 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $30.69 B | -7.28% |
2021-12-31 | $33.10 B | 4.12% |
2020-12-31 | $31.79 B | 20.67% |
2019-12-31 | $26.34 B | 4.91% |
2018-12-31 | $25.11 B | 2.88% |
2017-12-31 | $24.41 B | -1.74% |
2016-12-31 | $24.84 B | -6.31% |
2015-12-31 | $26.51 B | 23.88% |
2014-12-31 | $21.40 B | -14.59% |
2013-12-31 | $25.06 B | 21.83% |
2012-12-31 | $20.56 B | 17.44% |
2011-12-31 | $17.51 B | -2.05% |
2010-12-31 | $17.88 B | 2.45% |
2009-12-31 | $17.45 B | 179.7% |
2008-12-31 | $6.24 B | 8.73% |
2007-12-31 | $5.73 B | -16.04% |
2006-12-31 | $6.83 B | -15.58% |
2005-12-31 | $8.09 B | 17.82% |
2004-12-31 | $6.87 B | 1.13% |
2003-12-31 | $6.79 B | -20.5% |
2002-12-31 | $8.54 B | -3.57% |
2001-12-31 | $8.86 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $39.65 B | 29.22% | ๐บ๐ธ USA |
![]() Novartis NVS | $29.20 B | -4.85% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $34.87 B | 13.62% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $17.71 B | -42.28% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $18.88 B | -38.47% | ๐บ๐ธ USA |
![]() Amgen AMGN | $61.59 B | 100.69% | ๐บ๐ธ USA |
![]() Sanofi SNY | $22.71 B | -25.98% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $39.37 B | 28.28% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $25.89 B | -15.62% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $21.56 B | -29.75% | ๐ฎ๐ฑ Israel |